GNH USA

Europe — EMA

Nifuroxazide Lavipharm

GNH USA supplies Nifuroxazide Lavipharm (Nifuroxazide), a nitrofuran antibacterial for acute infectious diarrhea and traveler’s diarrhea.

Nifuroxazide

Request sourcing

1
Pack/s

What is Nifuroxazide?

Nifuroxazide, the active ingredient in Nifuroxazide Lavipharm, is a nitrofuran antibacterial presented as a tablet for oral use. It is indicated for the treatment of acute infectious diarrhea and traveler’s diarrhea caused by susceptible bacteria, providing symptomatic relief and helping to eradicate the pathogenic organisms in both adult and pediatric patients.

GNH USA supplies Nifuroxazide Lavipharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

What is Nifuroxazide used for?

Nifuroxazide is a nitrofuran antibacterial used to manage bacterial gastrointestinal infections.

Acute infectious diarrhea: reduces duration and severity of bacterial diarrhea. Traveler’s diarrhea: provides symptomatic relief and eradicates causative bacteria in travelers. Acute bacterial gastroenteritis: helps control infection and limits fluid loss in patients with bacterial gastroenteritis.

What are the side effects of Nifuroxazide?

Nifuroxazide may cause adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild stomach upset. - Abdominal pain: cramping. - Flatulence: increased intestinal gas. - Rash: mild skin irritation.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction. - Stevens‑Johnson syndrome: rare severe skin disorder. - Hepatotoxicity: elevated liver enzymes indicating liver injury. - Clostridioides difficile infection: severe colitis following bacterial imbalance.

What precautions apply to Nifuroxazide?

When prescribing Nifuroxazide, several precautions should be considered to ensure safe use.

- Indication: use only for confirmed or strongly suspected bacterial diarrhea. - Contraindication: avoid in patients with known hypersensitivity to nitrofurans. - Viral infections: not effective for viral gastroenteritis; avoid use. - Hepatic impairment: use with caution in patients with liver disease. - Renal impairment: dose adjustment may be needed in severe renal dysfunction. - Pregnancy and lactation: safety not established; weigh risks and benefits. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

What does Nifuroxazide interact with?

Nifuroxazide can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Warfarin: may increase anticoagulant effect and bleeding risk. - Live vaccines: concurrent use may reduce vaccine efficacy. - Probenecid: may raise nifuroxazide plasma concentrations.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in contraceptive effectiveness. - Antacids containing aluminum or magnesium: may decrease nifuroxazide absorption. - Diuretics: may enhance electrolyte disturbances. - Rifampicin: may reduce nifuroxazide levels.

Frequently asked questions

What is Nifuroxazide Lavipharm used for?+
Nifuroxazide Lavipharm is an oral nitrofuran antibacterial indicated for the treatment of acute infectious diarrhea and traveler’s diarrhea caused by susceptible bacterial pathogens. It helps to reduce the duration of symptoms and assists in eliminating the causative organisms in both adults and children.
How does nifuroxazide work?+
Nifuroxazide penetrates bacterial cells in the gastrointestinal tract and is reduced to reactive nitro‑radical species. These intermediates damage bacterial DNA, inhibit protein synthesis and interfere with key metabolic enzymes, resulting in a bacteriostatic effect against a range of Gram‑positive and Gram‑negative bacteria.
What is the usual dose of nifuroxazide?+
The dosage of Nifuroxazide Lavipharm is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of infection and local treatment guidelines. Patients should follow the prescriber’s instructions and the information provided on the product label.
Is nifuroxazide safe during pregnancy or breastfeeding?+
Safety data for nifuroxazide in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider after a thorough risk‑benefit assessment.
How do I order Nifuroxazide Lavipharm from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does nifuroxazide compare with other antidiarrheal agents?+
Unlike symptomatic agents such as loperamide, nifuroxazide has antibacterial activity that targets the underlying bacterial cause of diarrhea. It is comparable to other nitrofuran antibiotics but differs from broad‑spectrum agents by remaining largely confined to the intestinal lumen, which reduces systemic exposure.
What are the recommended storage conditions for nifuroxazide Lavipharm?+
The product should be stored at room temperature, preferably below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the tablets away from children and do not use after the expiry date printed on the label.
How is nifuroxazide administered?+
Nifuroxazide Lavipharm is taken orally, usually with a glass of water. The tablets should be swallowed whole and not chewed or crushed, unless otherwise directed by a healthcare professional. Administration is typically after meals to reduce gastrointestinal irritation.
What are the most serious risks associated with nifuroxazide?+
The most serious adverse reactions include severe allergic responses such as anaphylaxis, rare skin disorders like Stevens‑Johnson syndrome or toxic epidermal necrolysis, significant liver enzyme elevations indicating hepatotoxicity, and the potential for Clostridioides difficile‑associated colitis.
Who should not use nifuroxazide?+
Individuals with a known hypersensitivity to nifuroxazide or other nitrofuran compounds should avoid the medication. It is also contraindicated in patients with viral gastroenteritis, and caution is advised in those with severe hepatic or renal impairment, unless a prescriber determines that benefits outweigh risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Nifuroxazide
Route
Oral Use
Manufacturer
Lavipharm S.A
Origin
EU

Related products

Diarine

Diarine

Nifuroxazide

Lavipharm S.A
EU
Ercefuryl

Ercefuryl

Nifuroxazide

Takeda Gmbh
EU
Nifuroksazyd Aflofarm

Nifuroksazyd Aflofarm

Nifuroxazide

Aflofarm Farmacja Polska Sp. Z O.O.
EU
Nifuroksazyd Gedeon Richter

Nifuroksazyd Gedeon Richter

Nifuroxazide

Gedeon Richter Polska Sp. Z. O.O.
EU